Ocumetics Technology (TSXV:OTC,OTCQB:OTCFF,FWB:2QBO) has successfully completed a biocompatibility animal study for its proprietary Ocumetics Accommodating Lens, and according to President and CEO Dean Burns, the company is gearing up to…
Marvel Discovery Corp. (TSX-V: MARV), (Frankfurt: O4T), (MARVF: OTCQB); (the “Company”) is pleased to announce a non-brokered private placement (the “Offering”) to raise total proceeds of $750,000 by issuing up…
Marvel Discovery (TSXV:MARV,OTCQB:MARVF,FWB:O4T1) President and CEO Karim Rayani believes the company is going to perform well in the uranium space amid an adverse global political and economic environment. “The world…
Purepoint Uranium (TSXV:PTU,OTCQB:PTUUF) President and CEO Chris Frostad is optimistic that there will be a stronger uranium market in the next six to 12 months reminiscent of how it was…